🇺🇸 FDA
Patent

US 11919868

Heterocyclic compounds and related methods

granted A61PA61P31/04

Quick answer

US patent 11919868 (Heterocyclic compounds and related methods) held by Recursion Pharmaceuticals, Inc. expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Recursion Pharmaceuticals, Inc.
Grant date
Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P31/04